Clinical Trial Update: Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial completed evaluating the therapeutic dosage of fondaparinux sodium to prevent blood clots in morbidly obese volunteers, examining venous …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Fondaparinux (Arixtra) (Fondaparinux sodium)

Snippet

Sponsor: University of Pittsburgh | Conditions: Venous Thrombosis, Pulmonary Embolism | Phase 2 | Status: COMPLETED